Jun 20 |
NextCure to Present at the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference
|
May 30 |
NextCure Presents Phase 1b Data on NC410 and Pembrolizumab Combination at ASCO 2024
|
May 2 |
NextCure GAAP EPS of -$0.61 misses by $0.15
|
May 2 |
NextCure Provides Business Update and Reports First Quarter 2024 Financial Results
|
Apr 24 |
NextCure to Present Phase 1b Data of NC410 in Combination with Pembrolizumab at ASCO 2024
|
Apr 8 |
NextCure and LCB Present Preclinical Data on B7-H4 Antibody Drug Conjugate at AACR 2024
|
Apr 4 |
NextCure Appoints Dr. Rakesh Dixit to Scientific Advisory Board
|
Apr 2 |
NextCure to Present at 23rd Annual Needham Virtual Healthcare Conference
|
Mar 27 |
Will NextCure (NASDAQ:NXTC) Spend Its Cash Wisely?
|
Mar 21 |
NextCure GAAP EPS of -$2.25 beats by $0.02
|